Wednesday, May 13, 2026 | 01:26 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Dr Lal Pathlabs Ltd Quarterly Results

Q4 FY25-26 Results Summary

Revenue

The revenue stands at ₹702.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.50 per cent from ₹659.80 crore. This corresponds to a year-on-year *(YoY) growth of 16.61 per cent.

Operating Profit

Operating Profit stands at ₹186.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.20 per cent from ₹149.20 crore. This corresponds to a year-on-year *(YoY) growth of 10.53 per cent.

PBDT

PBDT stands at ₹204.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 23.02 per cent from ₹166.40 crore. This corresponds to a year-on-year *(YoY) growth of 7.85 per cent.

Profit Before Tax

Profit Before Tax stands at ₹160.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.80 per cent from ₹124.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.37 per cent.

Net Profit

Net Profit stands at ₹132.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.64 per cent from ₹91.40 crore. This represents a 14.98 per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Dr Lal Pathlabs Ltd Earnings

Data not available

Dr Lal Pathlabs Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Dr Lal Pathlabs Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 1,740HDFC Securities31-Dec-2025
Accumulate 2,910HDFC Securities17-Mar-2025
Buy 2,800Emkay Global20-Jun-2024

Dr Lal Pathlabs Ltd Financial Reports

Filter By:
Loading...

Dr Lal Pathlabs Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Dr Lal Pathlabs0.22%1.68%10.84%12.00%1.04%13.51%
Narayana Hrudaya-0.20%-1.39%2.17%-0.02%4.72%3.26%
Global Health0.92%-0.86%10.67%5.15%2.42%-3.04%
Krishna Institu.3.72%10.06%16.90%13.69%17.08%21.60%
Syngene Intl.-2.51%-0.93%12.53%6.91%-28.91%-27.43%
Poly Medicure-4.03%-3.20%10.41%24.93%-16.32%-30.85%
Dr Agarwal's Hea-1.02%-0.45%0.64%-1.00%-14.19%16.45%

Company Info

Company Information

Chairman cum Managing Director : Arvind Lal

Whole-time Director : Vandana Lal

Whole Time Director & CEO : Om Prakash Manchanda

Director : Rahul Sharma

Independent Director : Arun Duggal

Independent Director : Anoop Mahendra Singh

Independent Director : Sunil Varma

Independent Director : Harneet Singh Chandhoke

Independent Director : Saurabh Srivastava

Company Secretary : Rajat Kalra

Dr Lal Pathlabs Ltd News

Data Not Available